Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity

Authors

  • Mandana Khodashahi MD of Rheumatology, Assistant Professor, Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Keywords:

Rheumatoid arthritis; Cartilage oligomeric matrix protein (COMP); Extracellular matrix proteins

Abstract

Background: Serum cartilage oligomeric matrix protein (COMP) is a non-collagen glycoprotein produced by the cartilage, synovium, tendon, and meniscus. Recent studies showed that COMP is a reliable factor for monitoring cartilage damage.  Objective: To determine the relationship between serum COMP concentration and the severity of rheumatoid arthritis (RA).  Methods: This cross-sectional study lasted from 2013 to 2015 at the Rheumatology Clinic of Ghaem Hospital, Mashhad, Iran. The study population consisted of eligible patients who presented to our clinic during the study period. Four groups (150 subjects) were included as early RA (50 patients), late RA (50 patients), grades II and III OA (osteoarthritis) (25 cases, 17 grade II and 8 grade III joint destruction), and healthy controls (25 individuals). These were included consecutively. Serum COMP level was assessed by sandwich ELISA technique. In addition, ESR, hs-CRP, serum RF, and anti-CCP were assayed. X-rays of the knees (in OA) and hands (in RA) were examined for the degree of joint damage/erosion using the Short Erosion Scale (SES) in RA and Kellgren-Lawrence grading in OA. Analysis of variance (ANOVA) to compare mean COMP level among the groups and ROC (Receiver Operating Characteristic) analysis to determine the diagnostic accuracy of COMP in diagnosis of late RA were used by SPSS software (ver. 20.0).      Results: Mean (±SD) serum COMP levels were 18 (±10.6) U/L in early RA, 19.3 (±9.6) U/L in late RA, 10.9 (±4.5) U/L in OA, and 4.2 (±3.8) in controls; p<0.001. Serum COMP level was higher in RA and OA groups when compared to control group. Mean (±SD) SES score was 13.5 (±7.5) in early RA and 16.4 (±9.7) in late RA (p=0.093). There was a significant positive correlation between COMP level and disease severity in early RA (r=0.677, p<0.001) as well as in late RA (r=0.753, p<0.001). Serum COMP level at a concentration of 15.25 U/L had a sensitivity of 68% and specificity of 70% to discriminate late RA from early RA (area under curve= 69% (95% CI: 58% to 79%; p=0.001). Conclusion: COMP had positive significant correlation with early and late RA severity. This serum biomarker can be a useful and easy tool for monitoring of RA patients either at early or late stages of the disease.

 

References

Rudan I, Sidhu S, Papana A, Meng SJ, Xin-Wei Y, Wang W, et al. Prevalence of rheumatoid arthritis in

low- and middle-income countries: A systematic review and analysis. J Glob Health 2015;5 (1): 010409.

PMid: 25969732, PMCid: PMC4416333

Pruijn GJ. Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis. Front Immunol

; 6: 192. doi: 10.3389/fimmu.2015.00192, PMid: 25964785, PMCid: PMC4410602

Khanna R, Dlouhy BJ, Smith ZA, Lam SK, Koski TR, Dahdaleh NS. The impact of steroids, methotrexate,

and biologics on clinical and radiographic outcomes in patients with rheumatoid arthritis undergoing

fusions at the craniovertebral junction. J Craniovertebr Junction Spine 2015;6(2):60-4. doi: 10.4103/0974- 8237.156044, PMid: 25972710, PMCid: PMC4426523

Van Vilsteren M, Boot CR, Knol DL, van Schaardenburg D, Voskuyl AE, Steenbeek R, et al. Productivity

at work and quality of life in patients with rheumatoid arthritis. BMC Musculoskelet Disord 2015;16:107.

doi: 10.1186/s12891-015-0562-x, PMid: 25940578, PMCid: PMC4425924

Gurol G, Ciftci IH, Harman H, Karakece E, Kamanli A, Tekeoglu I. Roles of claudin-5 and von Willebrand

factor in patients with rheumatoid arthritis. Int J Clin Exp Pathol 2015;8(2):1979-84. PMid: 25973092,

PMCid: PMC4396339

Mocelin V, Nisihara RM, Utiyama SR, Kotze LM, Ramos O, Jr., Messias-Reason I. Anti-CCP Antibodies

and Rheumatological Findings in Brazilian Patients with Crohn's Disease. Digestion 2015;91(4):303-6. doi:

1159/000369899, PMid: 25925094

Vignesh AP, Srinivasan R. Ocular manifestations of rheumatoid arthritis and their correlation with anti- cyclic citrullinated peptide antibodies. Clin Ophthalmol 2015;9:393-7. PMid: 25750517, PMCid:

PMC4348132

Krabbe S, Bolce R, Brahe CH, Dohn UM, Ejbjerg BJ, Hetland ML, et al. Investigation of a multi- biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging,

computed tomography, ultrasonography, and radiography parameters of inflammation and damage. Scand J

Rheumatol 2017;46(5):353-358. doi: 10.1080/03009742.2016.1211315, PMid: 27682742

Saxne T, Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable

in synovial fluid and blood. Br J Rheumatol 1992;31(9):583-91. doi: 10.1093/rheumatology/31.9.583,

PMid: 1381980

Robinson WH, Lindstrom TM, Cheung RK, Sokolove J. Mechanistic biomarkers for clinical decision

making in rheumatic diseases. Nat Rev Rheumatol 2013;9(5):267-76. doi: 10.1038/nrrheum.2013.14,

PMid: 23419428, PMCid: PMC3673766

Andersson ML, Svensson B, Petersson IF, Hafstrom I, Albertsson K, Forslind K, et al. Early increase in

serum-COMP is associated with joint damage progression over the first five years in patients with

rheumatoid arthritis. BMC Musculoskelet Disord 2013;14:229. doi: 10.1186/1471-2474-14-229, PMid:

, PMCid: PMC3750296

Wislowska M, Jablonska B. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and

knee osteoarthritis. Clin Rheumatol 2005;24(3):278-84. doi: 10.1007/s10067-004-1000-x, PMid: 15940561

Sakthiswary R, Rajalingam S, Hussein H, Sridharan R, Asrul AW. Cartilage oligomeric matrix protein

(COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease

activity. Clin Rheumatol 2017. doi: 10.1007/s10067-017-3817-0, PMid: 28889184

Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligomeric matrix protein. A predicting factor

and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol

;32(3):156-61. doi: 10.1080/03009740310002498, PMid: 12892252

Syversen SW, Goll GL, van der Heijde D, Landewe R, Gaarder PI, Odegard S, et al. Cartilage and bone

biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. J Rheumatol

;36(2):266-72. doi: 10.3899/jrheum.080180, PMid: 19132792

El Defrawy AO, Gheita TA, Raslan HM, El Ansary MM, El Awar AH. Serum and synovial cartilage

oligomeric matrix protein levels in early and established rheumatoid arthritis. Z Rheumatol

;75(9):917-923. doi: 10.1007/s00393-015-1647-5, PMid: 26683321

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis

classification criteria: an American College of Rheumatology/European League Against Rheumatism

collaborative initiative. Arthritis Rheum 2010;62(9):2569-81. doi: 10.1002/art.27584, PMid: 20872595

Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the

classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and

Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum

;29(8):1039-49. doi: 10.1002/art.1780290816, PMid: 3741515

Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, et al. Biomarkers predict

radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.

Arthritis Rheum 2007;56(10):3236-47. doi: 10.1002/art.22923, PMid: 17907159

Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr 2015;38(3):93-4. doi:

18773/austprescr.2015.034, PMid: 26648629, PMCid: PMC4653962

Braschi E, Shojania K, Allan GM. Anti-CCP: a truly helpful rheumatoid arthritis test? Can Fam Physician

;62(3):234. PMid: 26975916, PMCid: PMC4984588

Wolfe F, van der Heijde DM, Larsen A. Assessing radiographic status of rheumatoid arthritis: introduction

of a short erosion scale. J Rheumatol 2000;27(9):2090-9. PMid: 10990218

Schiphof D, Boers M, Bierma-Zeinstra SM. Differences in descriptions of Kellgren and Lawrence grades

of knee osteoarthritis. Ann Rheum Dis 2008;67(7):1034-6. doi: 10.1136/ard.2007.079020, PMid: 18198197

Christensen AF, Lindegaard H, Horslev-Petersen K, Hetland ML, Ejbjerg B, Stengaard-Pedersen K, et al.

Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different

temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early

rheumatoid arthritis. J Rheumatol 2011;38(8):1563-8. doi: 10.3899/jrheum.101241, PMid: 21572145

Krabben A, Huizinga TW, Mil AH. Biomarkers for radiographic progression in rheumatoid arthritis. Curr

Pharm Des 2015;21(2):147-69. doi: 10.2174/1381612820666140825122525, PMid: 25163742

Papamichael K, Tsirogianni A, Papasteriades C, Mantzaris GJ. Low prevalence of antibodies to cyclic

citrullinated peptide in patients with inflammatory bowel disease regardless of the presence of arthritis. Eur

J Gastroenterol Hepatol 2010;22(6):705-9. PMid: 19525851

Algergawy SA, Abd El-Sabour M, Osman AS, Emam SM, Elham N. Early diagnostic and prognostic

values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid

arthritis. Egypt J Immunol 2013;20(2):11-20. PMid: 24617043

Denarie D, Constant E, Thomas T, Marotte H. Could biomarkers of bone, cartilage or synovium turnover

be used for relapse prediction in rheumatoid arthritis patients? 2014;2014:537324.

Vilim V, Vytasek R, Olejarova M, Machacek S, Gatterova J, Prochazka B, et al. Serum cartilage

oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee

osteoarthritis. Osteoarthritis Cartilage 2001;9(7):612-8. doi: 10.1053/joca.2001.0434, PMid: 11597173

Soderlin MK, Kastbom A, Kautiainen H, Leirisalo-Repo M, Strandberg G, Skogh T. Antibodies against

cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early

arthritis: relation to diagnosis and disease activity. Scand J Rheumatol 2004;33(3):185-8. doi:

1080/03009740310004856, PMid: 15228190

Jilani AA, Mackworth-Young CG. The role of citrullinated protein antibodies in predicting erosive disease

in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol

;2015:728610. doi: 10.1155/2015/728610, PMid: 25821469, PMCid: PMC4364370

Acharya C, Yik JH, Kishore A, Van Dinh V, Di Cesare PE, Haudenschild DR. Cartilage oligomeric matrix

protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in

chondrogenesis. Matrix Biol 2014;37:102-11. doi: 10.1016/j.matbio.2014.06.001, PMid: 24997222

Published

2022-02-12